Sp Labs Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-07-2024
- Paid Up Capital ₹ 0.10 M
as on 17-07-2024
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 25.00 Cr
as on 17-07-2024
- Satisfied Charges ₹ 6.00 Cr
as on 17-07-2024
- Revenue %
(FY 2023)
- Ebitda
- Net Worth
- Total Assets 0.02%
(FY 2023)
About Sp Labs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹25.00 Cr. The company has closed loans amounting to ₹6.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vijayaprakash Katikala and Manikya Kodali serve as directors at the Company.
- CIN/LLPIN
U24232AP2014PTC095084
- Company No.
095084
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Aug 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Vijayawada, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sp Labs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijayaprakash Katikala  | Director | 18-Aug-2014 | Current |
| Manikya Kodali | Director | 18-Aug-2014 | Current |
Financial Performance of Sp Labs.
Sp Labs Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sp Labs?
In 2023, Sp Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sanozen Pharma Private LimitedActive 8 years 7 monthsVijayaprakash Katikala and Manikya Kodali are mutual person
Sppt Chem Private LimitedActive 11 years 6 daysVijayaprakash Katikala and Manikya Kodali are mutual person
- Sp Accure Labs Private LimitedActive 11 years 3 months
Vijayaprakash Katikala and Manikya Kodali are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 25 May 2023 | ₹25.00 Cr | Open |
Others Creation Date: 31 Mar 2016 | ₹6.00 Cr | Satisfied |
How Many Employees Work at Sp Labs?
Unlock and access historical data on people associated with Sp Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sp Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sp Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.